Victory Capital Management Inc. increased its holdings in shares of Amdocs Limited (NASDAQ:DOX - Free Report) by 1.9% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 478,137 shares of the technology company's stock after buying an additional 9,098 shares during the period. Victory Capital Management Inc. owned about 0.41% of Amdocs worth $41,827,000 at the end of the most recent quarter.
A number of other hedge funds also recently added to or reduced their stakes in the business. Pzena Investment Management LLC boosted its stake in shares of Amdocs by 33.2% in the 2nd quarter. Pzena Investment Management LLC now owns 5,667,603 shares of the technology company's stock valued at $447,287,000 after buying an additional 1,412,826 shares during the period. LSV Asset Management raised its holdings in Amdocs by 7.9% in the second quarter. LSV Asset Management now owns 3,207,155 shares of the technology company's stock valued at $253,109,000 after acquiring an additional 234,096 shares in the last quarter. Allspring Global Investments Holdings LLC lifted its stake in Amdocs by 36.6% in the third quarter. Allspring Global Investments Holdings LLC now owns 3,175,790 shares of the technology company's stock worth $277,818,000 after acquiring an additional 851,022 shares during the last quarter. Brandes Investment Partners LP grew its holdings in Amdocs by 31.1% during the 2nd quarter. Brandes Investment Partners LP now owns 2,260,811 shares of the technology company's stock worth $178,335,000 after acquiring an additional 536,359 shares in the last quarter. Finally, Vanguard Group Inc. increased its position in shares of Amdocs by 39.5% in the 1st quarter. Vanguard Group Inc. now owns 2,033,536 shares of the technology company's stock valued at $183,771,000 after purchasing an additional 576,168 shares during the last quarter. 92.02% of the stock is currently owned by institutional investors and hedge funds.
Amdocs Price Performance
Shares of Amdocs stock traded down $1.73 on Friday, hitting $83.98. The company's stock had a trading volume of 943,960 shares, compared to its average volume of 683,137. The firm has a fifty day moving average price of $88.16 and a 200-day moving average price of $83.95. The company has a market capitalization of $9.87 billion, a P/E ratio of 19.81, a price-to-earnings-growth ratio of 1.42 and a beta of 0.74. Amdocs Limited has a 52-week low of $74.41 and a 52-week high of $94.04. The company has a quick ratio of 1.24, a current ratio of 1.24 and a debt-to-equity ratio of 0.21.
Amdocs Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Tuesday, December 31st will be issued a $0.479 dividend. The ex-dividend date is Tuesday, December 31st. This represents a $1.92 dividend on an annualized basis and a yield of 2.28%. Amdocs's dividend payout ratio (DPR) is 45.05%.
Wall Street Analyst Weigh In
Several equities research analysts have recently issued reports on the stock. Barclays decreased their price objective on shares of Amdocs from $113.00 to $111.00 and set an "overweight" rating for the company in a research report on Thursday. Stifel Nicolaus started coverage on Amdocs in a research report on Wednesday, October 2nd. They set a "buy" rating and a $100.00 price objective for the company. Oppenheimer increased their price objective on Amdocs from $98.00 to $105.00 and gave the company an "outperform" rating in a report on Wednesday. Finally, StockNews.com cut Amdocs from a "strong-buy" rating to a "buy" rating in a research note on Thursday. One research analyst has rated the stock with a hold rating and six have given a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average target price of $101.83.
View Our Latest Report on DOX
Amdocs Company Profile
(
Free Report)
Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.
Read More
Before you consider Amdocs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amdocs wasn't on the list.
While Amdocs currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.